Literature DB >> 26392457

Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit.

Geneviève Digby1, Shirin Jalini1, Sean Taylor1.   

Abstract

A 62-year-old man presented with left middle cerebral artery stroke. 1 h postadministration of tissue plasminogen activator, he received a total of 4 mg of haloperidol for combativeness. He developed partial complex status epilepticus, requiring benzodiazepines, phenytoin, propofol and intubation. 5 h later, he developed recurrent stereotyped tonic movements involving arching of the back, extension of the arms and contraction of opposing muscle groups. Repeat CT scan of the head showed evolving insular infarct. Differential diagnoses for these movements included tonic/clonic seizures, extensor (decerebrate) posturing from haemorrhagic conversion, neuroleptic malignant syndrome, or dystonic reaction. Given the lack of response to antiseizure medications, the recent administration of haloperidol, and the prompt resolution of movements following diphenhydramine administration, an acute dystonic reaction was considered. This atypical case of a critically ill patient with stroke highlights the fact that these patients may have multiple abnormal movements requiring careful analysis to guide diagnosis-specific management. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26392457      PMCID: PMC4577690          DOI: 10.1136/bcr-2014-207215

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Prevalence and predictors of early seizure and status epilepticus after first stroke.

Authors:  D L Labovitz; W A Hauser; R L Sacco
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

Review 2.  Frontal lobe seizures.

Authors:  Barbara C Jobst; Peter D Williamson
Journal:  Psychiatr Clin North Am       Date:  2005-09

3.  Seizures after stroke: a prospective multicenter study.

Authors:  C F Bladin; A V Alexandrov; A Bellavance; N Bornstein; B Chambers; R Coté; L Lebrun; A Pirisi; J W Norris
Journal:  Arch Neurol       Date:  2000-11

Review 4.  "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects.

Authors:  Su Ling Young; Mark Taylor; Stephen M Lawrie
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

Review 5.  Antipsychotic medication and seizures: a review.

Authors:  Dawson Hedges; Kreg Jeppson; Paul Whitehead
Journal:  Drugs Today (Barc)       Date:  2003-07       Impact factor: 2.245

Review 6.  Delirium in acute stroke: a review.

Authors:  A W Oldenbeuving; P L M de Kort; B P W Jansen; G Roks; L J Kappelle
Journal:  Int J Stroke       Date:  2007-11       Impact factor: 5.266

Review 7.  Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.

Authors:  M Tonini; L Cipollina; E Poluzzi; F Crema; G R Corazza; F De Ponti
Journal:  Aliment Pharmacol Ther       Date:  2004-02-15       Impact factor: 8.171

Review 8.  Antipsychotics for delirium.

Authors:  E Lonergan; A M Britton; J Luxenberg; T Wyller
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

Review 9.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

10.  Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.

Authors:  John W Devlin; Russel J Roberts; Jeffrey J Fong; Yoanna Skrobik; Richard R Riker; Nicholas S Hill; Tracey Robbins; Erik Garpestad
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

View more
  1 in total

Review 1.  Hyperkinetic Movement Disorder Emergencies.

Authors:  Giovanni Cossu; Carlo Colosimo
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.